FMP

FMP

Enter

LHDX - Lucira Health, Inc.

Profile of Lucira Health, Inc.(LHDX), Lucira Health, Inc., a medical technology company, focuses on the development and commercialization

About

ceo

Mr. Erik T. Engelson

sector

Healthcare

industry

Medical - Devices

website

https://www.lucirahealth.com

exchange

NASDAQ

Description

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.

CIK

0001652724

ISIN

US54948U1051

CUSIP

54948U105

Address

1412 62nd Street

Phone

510 350 8071

Country

US

Employee

221

IPO Date

Feb 4, 2021

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep